KROLL MARK W

SEC Form 4 insider trading activity

KROLL MARK W has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 2 of those filings fall inside the rolling window. Most recent filing: Jul 28, 2026.

On the most recent filing, KROLL MARK W is listed as Director at HAEMONETICS CORP. Inside the rolling window, KROLL MARK W reported 1 open-market purchase totaling $99K in HAE and no open-market sales.

Companies traded

Other insiders at HAE

Insider Buying

$99K

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
HAE
KROLL MARK W
Purchase$99KNov 12SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has KROLL MARK W made?

KROLL MARK W has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.

Which companies does KROLL MARK W trade?

KROLL MARK W has filed SEC Form 4 disclosures for 1 company, including HAE.

When was KROLL MARK W's most recent SEC Form 4 filing?

KROLL MARK W's most recent SEC Form 4 filing on Tracefour is dated Jul 28, 2026.

What is KROLL MARK W's total buy and sell value in the current window?

Inside the rolling retention window, KROLL MARK W bought $99K and sold $0 based on SEC Form 4 filings.

What was KROLL MARK W's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 1,400 HAE shares on 2025-11-10, worth $99K, per SEC Form 4 filings.